- Department of Neurosurgery, U.S. Department of Veterans Affairs Medical Center, Milwaukee, USA
- Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, USA
- Department of Surgery/Division of Otolaryngology, University of Wisconsin, Madison, Wisconsin, USA
- Department of Otolaryngology and Communication Science, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Elsa V. Arocho-Quinones
Department of Neurosurgery, U.S. Department of Veterans Affairs Medical Center, Milwaukee, USA
Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, USA
DOI:10.4103/2152-7806.200580Copyright: © 2017 Surgical Neurology International This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
How to cite this article: Elsa V. Arocho-Quinones, Michael J. Hammer, Jonathan M. Bock, Peter A. Pahapill. Effects of deep brain stimulation on vocal fold immobility in Parkinson's disease. 20-Feb-2017;8:22
How to cite this URL: Elsa V. Arocho-Quinones, Michael J. Hammer, Jonathan M. Bock, Peter A. Pahapill. Effects of deep brain stimulation on vocal fold immobility in Parkinson's disease. 20-Feb-2017;8:22. Available from: http://surgicalneurologyint.com/surgicalint_articles/effects-of-deep-brain-stimulation-on-vocal-fold-immobility-in-parkinsons-disease/
Background:Vocal fold (VF) immobility is a rare, potentially fatal complication of advanced Parkinson's disease (PD). Previous reports suggest that subthalamic nucleus deep brain stimulation (STN-DBS) may influence laryngeal function, yet the role of STN-DBS on VF immobility remains unexplored.
Case Description:We report a case of a patient with advanced PD and bilateral VF immobility ultimately requiring a tracheostomy. To assess the effects of STN-DBS on vocal cord function and to correlate these effects with peripheral motor symptoms at different stimulation settings, the patient was evaluated before and after initiation of bilateral STN-DBS. Measures included direct observation of VF mobility via transnasal laryngoscopy, levodopa equivalent dose of anti-PD medication, and motor scores. High frequency (150 Hz) STN-DBS resulted in improved motor scores, reduced medication requirement, and modestly improved right VF abduction although insufficient for safe decannulation. Low frequency (60 Hz) stimulation resulted in lower motor scores, but without worsening VF abduction.
Conclusions:STN-DBS may play an important role in the neuromodulation of PD-induced laryngeal dysfunction, including VF mobility. Characterization of these axial symptoms is important when programming and evaluating responsiveness to DBS.
Keywords: DBS, laryngeal dysfunction, Parkinson's disease, STN, vocal fold immobility
The role of laryngeal dysfunction in the development of speech disorders in Parkinson's disease (PD) is well recognized.[
The patient was a 51-year-old male with progressive idiopathic PD. He was diagnosed with PD at age 41 and his symptoms began with left- greater than right-sided tremor that progressed to grade 2/4. He developed bradykinesia, rigidity, dyskinesias, and balance problems. He experienced speech difficulties which responded to medication and reported a 9-month history of noisy breathing that worsened after the discontinuation of his PD medications. He also reported reflux and mild dysphagia. Medications included amantadine, carbidopa/levodopa, rasagiline, and ropinirole.
Deep brain stimulation surgery
With the goal of improving his limb symptoms, the patient underwent implantation of subthalamic nucleus deep brain stimulation (STN-DBS) electrodes (Medtronic, model 3389) during separate awake procedures using microelectrode recording, microstimulation, and macrostimulation. The first electrode was placed in the right-STN, and the second in the left-STN 1 month later [
Computed tomography (CT) post STN-DBS electrode placement. (a) Axial view at the level of the most proximal (top) electrode contacts. (b) Axial view at level of most distal (bottom) electrode contacts. (c) Coronal view at level of most proximal electrode contact. (d) Coronal view at level of most distal contact. (e) Sagittal view showing right STN electrode. (f) Sagittal view showing left STN electrode contacts
After an uneventful placement of the right-STN electrode and prior to the placement of the left-STN electrode, the patient was referred to a pulmonologist for evaluation of possible obstructive airway disease. Pulmonary function testing revealed mild air trapping, mildly reduced diffusion capacity, and increased airway resistance. Inhaled bronchodilators did not improve these symptoms. Therefore, upper airway obstruction was suspected, and he was referred to Otolaryngology.
Upper airway evaluation via transnasal laryngoscopy revealed bilateral VF immobility with VFs at the paramedian position [
(A) Laryngoscopic images of laryngeal airway opening. T = True vocal folds; F = False vocal folds; Ep = Epiglottis; Ar = Arytenoids; * = Airway (space between vocal folds). (B) Schematic representation of vocal fold mobility. (a) True vocal fold adduction during phonation. (b) Vocal fold abduction during normal inspiration. (c) Vocal folds immobile at the paramedian position. (d) The left vocal fold appears immobile at the paramedian position while the right vocal fold is abducted during inspiration. TVC = True vocal cords/folds; FVC = False vocal cords/folds
Outcomes with subthalamic nucleus deep brain stimulation
Following initiation of bilateral STN-DBS, the patient was evaluated at several intervals during a period of 11 months [
At baseline, the anti-PD medication dose totaled 1660 mg LED and the UPDRS-III score was 57. Transnasal laryngoscopy revealed bilateral VF immobility with a maximum airway opening of 4 mm. Improvement in the UPDRS-III score was sustained at each measurement timepoint, with a 70–82% reduction in anti-PD medication with high frequency STN-DBS. While the left VF remained immobile at the paramedian position, the right VF abduction modestly increased with maximum airway opening of 6 mm with STN-DBS [
DBS ON vs. DBS OFF
On day 225 with DBS, the UPDRS-III score was 32, with an 82% reduction in medication. Right VF movement had improved to 3 mm, and maximal airway opening had increased to 6 mm. Speech was relatively clear with only mild dysphonia, no coughing, and no stridor with the tracheostomy capped (UPDRS Speech score: 2). On day 225, we also tested the patient after turning the stimulation off for 2 hours. Without DBS, the UPDRS-III score was 74, markedly worse than baseline of 57 and suggesting rapid disease progression. In addition, right VF movement returned to baseline, with maximal airway opening decreasing from 6 mm to 4 mm. We also observed an overall reduction in the tone of the VFs and increased laryngeal tremor. Without DBS, speech also became more effortful, less precise, and less intelligible (UPDRS Speech score: 4).
High Frequency (150 Hz) DBS vs. Low Frequency (60 Hz) DBS
On day 328, with high frequency DBS, the UPDRS-III score was 32, with a 70% reduction in medication. Right VF movement was 2.5 mm, and maximum airway opening was 5 mm. On day 328, we also tested this patient after turning the stimulation frequency to 60 Hz for 2 hours. With low frequency DBS, the UPDRS-III score was 65, markedly worse than that with high frequency DBS. VF movement and maximum airway opening were unchanged with low frequency DBS. We also observed a weaker voice with less intelligible speech (UPDRS Speech score: 3). However, it should be noted that this patient was nearing the time for his next dose of anti-PD medication.
The larynx is important to coordinate the life-sustaining functions of airway protection, cough, and swallow.[
High frequency STN-DBS has become a neuromodulation treatment of choice for advanced PD and is associated with marked improvements in limb motor function as evaluated by the UPDRS. Previous reports suggest that STN-DBS may influence laryngeal function related to vocalization and speech, yet the results remain controversial.[
High frequency STN-DBS in PD patients has been almost exclusively optimized for limb function. The forces generated by the limb musculature are far greater than those of laryngeal motor control. Therefore, high frequency STN-DBS may be of less benefit for the laryngeal musculature.[
In the present case, our patient exhibited marked improvements in limb motor function with STN-DBS that was accompanied by measurable but modest improvements in VF mobility. Although a rare finding in patients with PD, the mechanisms for VF immobility in PD may initially stem from rigidity of the intrinsic laryngeal muscles and reduced range of motion of the cricoarytenoid joint.[
Axial and limb symptoms may appear and progress differently across the midline, and each symptom may progress at different rates. The patient reported here exhibited limb symptoms that were more severe on the left. His impaired VF mobility was also more severe on the left, with the VF remaining immobile. This finding was consistent with laterality of axial symptoms. Therefore, the larynx offers a unique opportunity to compare the extent and laterality of axial and peripheral motor dysfunction in PD patients. Testing after two hours of low frequency STN-DBS resulted in more severe UPDRS scores compared with high frequency STN-DBS. However, the benefit to VF mobility was sustained and similar at each setting. The potential effects of longer intervals of low frequency stimulation on limb and laryngeal function will be important to explore in the future, as will examining the relative contribution of medication and DBS.
Bilateral VF immobility and respiratory stridor are potentially fatal complications of advanced PD. To our knowledge, this is the first report demonstrating STN-DBS influence on VF immobility under direct visualization via transnasal laryngoscopy. STN-DBS may influence various aspects of laryngeal sensorimotor control, including potential improvements in VF mobility as reported here. Comprehensive multidisciplinary assessment is critical to identify the complex clinical features in PD patients that may respond to or may result from STN-DBS to maximize the benefit of STN-DBS for both limb and axial sensorimotor symptoms. Detailed characterization of axial motor symptoms, including laryngeal dysfunction, may provide a marker of disease progression and serve as a tool to predict responsiveness to DBS.
Financial support and sponsorship
Dr. Hammer's work is funded by NIH grant DC014519.
Conflicts of interest
There are no conflicts of interest.
Christopher J. Sheridan, RN: Involved in organization of clinic appointments, DBS programming sessions, and clinical examinations.
1. Blumin JH, Pcolinsky DE, Atkins JP. Laryngeal findings in advanced parkinson's disease. Ann Otol Rhinol Laryngol. 2004. 113: 253-8
2. Chalif JI, Sitsapesan HA, Pattinson KT, Herigstad M, Aziz TZ, Green AL. Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for parkinson's disease. Respir Physiol Neurobiol. 2014. 192: 128-33
3. Fagbami OY, Donato AA. Stridor and dysphagia associated with subthalamic nucleus stimulation in parkinson disease. J Neurosurg. 2011. 115: 1005-6
4. Gan EC, Lau DP, Cheah KL. Stridor in parkinson's disease: A case of ‘dry drowning’?. J Laryngol Otol. 2010. 124: 668-73
5. Hammer MJ. Aerodynamic assessment of phonatory onset in parkinson's disease: Evidence of decreased scaling of laryngeal and respiratory control. J Parkinson's Dis. 2013. 3: 173-179
6. Hammer MJ, Barlow SM. Laryngeal somatosensory deficits in parkinson's disease: Implications for speech respiratory and phonatory control. Exp Brain Res. 2010. 201: 401-9
7. Hammer MJ, Murphy CA, Abrams TM. Airway somatosensory deficits and dysphagia in parkinson's disease. J Parkinson's Dis. 2013. 3: 39-44
8. Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in parkinson's disease. J Neurol. 2010. 257: 1692-702
9. Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in parkinson's disease. J Commun Disord. 2011. 44: 37-48
10. Holinger LD, Holinger PC, Holinger PH. Etiology of bilateral abductor vocal cord paralysis: A review of 389 cases. Ann Otol Rhinol Laryngol. 1976. 85: 428-36
11. Ilkay S, Acar G, Zisakis AK, Ozdemir M, Acar F, Burchiel KJ. Effect of Subthalamic Nucleus Stimulation on Pedunculopontine Nucleus Neural Activity. Stereotact Funct Neurosurg. 2016. 94: 54-9
12. Kim HJ, Jeon BS. Acute respiratory failure due to vocal cord paralysis in a patient with parkinson's disease. Mov Disord. 2009. 24: 1862-3
13. Klostermann F, Ehlen F, Vesper J, Nubel K, Gross M, Marzinzik F. Effects of subthalamic deep brain stimulation on dysarthrophonia in parkinson's disease. J Neurol Neurosurg Psychiatry. 2008. 79: 522-9
14. Lee DH, Lim SC, Lee JK. Bilateral vocal cord paralysis in a patient with parkinson's disease. B-ENT. 2012. 8: 141-2
15. Meyer TK. The larynx for neurologists. Neurologist. 2009. 15: 313-8
16. Montgomery EB. Deep brain stimulation and speech: A new model of speech function and dysfunction in parkinson's disease. J Med Speech Lang Pathol. 2007. 15: ix-xxv
17. Pahapill PA, Lozano AM. The pedunculopontine nucleus and parkinson's disease. Brain. 2000. 123: 1767-83
18. Phibbs FT, Arbogast PG, Davis TL. 60-hz frequency effect on gait in parkinson's disease with subthalamic nucleus deep brain stimulation. Neuromodulation. 2014. 17: 717-20
19. Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid AL. Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Mov Disord. 2005. 20: 1507-15
20. Plasse HM, Lieberman AN. Bilateral vocal cord paralysis in parkinson's disease. Arch Otolaryngol. 1981. 107: 252-3
21. Qayyum A, Mierzwa K, See M, Sharma A, Montgommery PQ. Laser arytenoidectomy for bilateral vocal fold palsy in parkinson's disease. J Laryngol Otol. 2005. 119: 831-3
22. Ramdhani RA, Patel A, Swope D, Kopell BH. Early use of 60 hz frequency subthalamic stimulation in parkinson's disease: A case series and review. Neuromodulation. 2015. 18: 664-9
23. Read D, Young A. Stridor and parkinsonism. Postgrad Med J. 1983. 59: 520-1
24. Skodda S. Effect of deep brain stimulation on speech performance in parkinson's disease. Parkinsons Dis 2012. 2012. p.
25. Skodda S, Gronheit W, Schlegel U, Sudmeyer M, Schnitzler A, Wojtecki L. Effect of subthalamic stimulation on voice and speech in parkinson's disease: For the better or worse?. Front Neurol. 2014. 4: 218-
26. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe parkinson's disease. Brain. 2007. 130: 1596-607
27. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in parkinson's disease. Mov Disord. 2010. 25: 2649-53
28. Tornqvist AL, Schalen L, Rehncrona S. Effects of different electrical parameter settings on the intelligibility of speech in patients with parkinson's disease treated with subthalamic deep brain stimulation. Mov Disord. 2005. 20: 416-23
29. Tripoliti E, Zrinzo L, Martinez-Torres I, Frost E, Pinto S, Foltynie T. Effects of subthalamic stimulation on speech of consecutive patients with parkinson disease. Neurology. 2011. 76: 80-6
30. Tripoliti E, Zrinzo L, Martinez-Torres I, Tisch S, Frost E, Borrell E. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord. 2008. 23: 2377-83
31. Xie T, Vigil J, MacCracken E, Gasparaitis A, Young J, Kang W. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with pd. Neurology. 2015. 84: 415-420
32. Yanase M, Kataoka H, Kawahara M, Hirabayashi H, Yamanaka T, Hirano M. Fixed epiglottis associated with subthalamic nucleus stimulation in parkinson's disease. J Neurol Neurosurg Psychiatry. 2008. 79: 332-3